v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 09, 2025
shares
Jan. 07, 2025
shares
Jan. 06, 2025
shares
Jul. 01, 2024
USD ($)
Jun. 03, 2024
shares
Jan. 26, 2024
USD ($)
shares
Oct. 06, 2023
USD ($)
Oct. 06, 2022
USD ($)
Oct. 03, 2022
Mar. 31, 2025
USD ($)
Jan. 31, 2025
shares
Jun. 30, 2012
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2025
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                                    
Net sales royalty percenatge                           3.00%        
Gross proceeds from cash fee percentage                 7.00%                  
Gross proceeds from management fee percentage                 1.00%                  
Stock issued during period, value, new issues                           $ 52,731 [1] $ 4,419 [2]      
Litigation settlement amount           $ 2,154                        
Liabilities current                           3,421 2,460      
Assets current                           79,822 5,819      
Settlement amount recovery                               $ 1,100    
Legal expense                               235    
Non operating loss on legal settlement                               1,111    
Proceeds from Legal Settlements                   $ 316                
Chief Executive Officer and Executives and Certain Employees [Member]                                    
Loss Contingencies [Line Items]                                    
Accrued bonuses current and non current                           1,089        
Integrated Product [Member]                                    
Loss Contingencies [Line Items]                                    
Royalties percentage               1.50%                    
Common Stock [Member]                                    
Loss Contingencies [Line Items]                                    
Stock issued during period, value, new issues                           $ 279 [1] $ 33 [2]      
Number of share issued | shares                           27,880,955 [1] 3,252,351 [2]      
At-the-Market Offering Agreement [Member] | Common Stock [Member]                                    
Loss Contingencies [Line Items]                                    
Aggregate offering       $ 4,820                            
Percentage of placement fee       3.00%                            
Number of share issued | shares                     842,606       3,433,880      
Securities Purchase Agreement [Member]                                    
Loss Contingencies [Line Items]                                    
Purchase price of plaintiffs                           $ 6,750        
Securities Purchase Agreement [Member] | Common Stock [Member]                                    
Loss Contingencies [Line Items]                                    
Number of share issued | shares 6,103,289 3,788,550 4,000,001   1,566,669                          
Litigation Settlement [Member]                                    
Loss Contingencies [Line Items]                                    
Payment for litigation settlement           $ 1,100             $ 1,100          
Restricted common shares issued for legal settlement | shares           1,005,965                        
Liabilities current                               2,211    
Assets current                               $ 1,335    
Insurance recovery amount                         $ 1,335          
Litigation Settlement [Member] | Common Stock [Member]                                    
Loss Contingencies [Line Items]                                    
Number of share issued | shares                         1,005,965          
Minimum [Member] | Device [Member]                                    
Loss Contingencies [Line Items]                                    
Royalties percentage               3.00%                    
Maximum [Member] | Device [Member]                                    
Loss Contingencies [Line Items]                                    
Royalties percentage               5.00%                    
Israeli Innovation Authority [Member]                                    
Loss Contingencies [Line Items]                                    
Grants receivable                           518        
Additional grant receivable                           $ 673     ₪ 2,153  
Israeli Innovation Authority [Member] | Minimum [Member]                                    
Loss Contingencies [Line Items]                                    
Net sales royalty percenatge                           3.00%        
Israeli Innovation Authority [Member] | Maximum [Member]                                    
Loss Contingencies [Line Items]                                    
Net sales royalty percenatge                           5.00%        
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                                    
Loss Contingencies [Line Items]                                    
Repayment of government grants             $ 925                      
Ministry of Economy [Member]                                    
Loss Contingencies [Line Items]                                    
Grants receivable                           $ 50        
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                                    
Loss Contingencies [Line Items]                                    
Net sales royalty percenatge                       1.50%            
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                                    
Loss Contingencies [Line Items]                                    
Net sales royalty percenatge                       3.00%            
H.C. Wainwright & Co. LLC [Member]                                    
Loss Contingencies [Line Items]                                    
Warrant or Right, Reason for Issuance, Description                 The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering. See also Note 11E below.                  
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                                    
Loss Contingencies [Line Items]                                    
Offering costs                                   $ 10,000
Stock issued during period, value, new issues               $ 8,000                    
2013 Through June 30, 2022 [Member] | Israeli Innovation Authority [Member]                                    
Loss Contingencies [Line Items]                                    
Revenues                           $ 2,468        
[1] Net of issuance costs in the amount of $5,155, of which $101 had not been paid as of December 31, 2025.
[2] Net of issuance costs in the amount of $661.